Difference between revisions of "Team:UCSC/Project"

Line 58: Line 58:
 
   font-size: 20px;
 
   font-size: 20px;
 
   padding: 16px 32px;
 
   padding: 16px 32px;
 +
}
 +
 +
.pagagraph {
 +
margin-left: 80px;
 +
margin-right: 80px;
 
}
 
}
  
Line 127: Line 132:
 
   -ms-transform: translate(-50%, -50%)
 
   -ms-transform: translate(-50%, -50%)
 
}
 
}
 +
 +
.pagagraph {
 +
margin-left: 10px;
 +
margin-right: 10px;
 +
}
 
}
 
}
  
Line 138: Line 148:
  
  
<div class="container" style="margin: 50px;">
+
<div class="container">
<!-- <div class="row justify-content-md-center">
+
<div class="col col-md-3">
+
<img src="https://static.igem.org/mediawiki/2017/f/f9/3synechobuddies.png">
+
</div>
+
<div class="col col-md-3">
+
<h1>Project<br>Description</h1>
+
</div>
+
</div>
+
 
+
<div class="row no-gutters justify-content-md-center">
+
<div class="col-sm-auto">
+
<img src="https://static.igem.org/mediawiki/2017/f/f9/3synechobuddies.png">
+
</div>
+
<div class="col-sm-auto">
+
<h1>Project Description</h1>
+
</div>
+
</div> -->
+
 
+
 
<div class="row no-gutters justify-content-md-center">
 
<div class="row no-gutters justify-content-md-center">
 
<div class="col-md-4">
 
<div class="col-md-4">
Line 165: Line 157:
 
</div>
 
</div>
 
</div>
 
</div>
 +
</div>
  
<!-- <div class="row justify-content-md-center">
+
<div class="container">
<div class="col">
+
<div class="paragraph">
<h1>Project<br>Description</h1>
+
<h2>We</h2><p>are using the cyanobacteria genus Synechococcus as a model for the FDA-approved Arthrospira platensis, commonly known as Spirulina. By focusing on an edible cyanobacteria, we hope to generate an easily consumable, photosynthetic culture of vitamin or pharmaceutical synthesizers.</p>
</div>
+
 
</div> -->
+
<p>Of the three non-opioid pain reducers on the World Health Organization’s (WHO) list of essential medicines, we have decided to pursue acetaminophen, the active ingredient in Tylenol, do to the feasibility of recreating the metabolic pathway in a cyanobacteria. With respect to vitamins, we aim to produce human usable vitamin B12 because it is one of the few vitamins that A. platensis does not adequately produce.</p>
</div>
+
  
 
   <div class="pageflow">
 
   <div class="pageflow">

Revision as of 20:35, 8 September 2017

Project Description

We

are using the cyanobacteria genus Synechococcus as a model for the FDA-approved Arthrospira platensis, commonly known as Spirulina. By focusing on an edible cyanobacteria, we hope to generate an easily consumable, photosynthetic culture of vitamin or pharmaceutical synthesizers.

Of the three non-opioid pain reducers on the World Health Organization’s (WHO) list of essential medicines, we have decided to pursue acetaminophen, the active ingredient in Tylenol, do to the feasibility of recreating the metabolic pathway in a cyanobacteria. With respect to vitamins, we aim to produce human usable vitamin B12 because it is one of the few vitamins that A. platensis does not adequately produce.

Click on an icon below to learn more about our project!